Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1887 1
1979 1
1983 1
1989 1
1990 1
1995 1
1997 2
1998 1
1999 5
2000 1
2001 1
2002 5
2003 4
2004 2
2005 4
2006 2
2007 2
2008 7
2009 6
2010 4
2011 5
2012 3
2013 4
2014 9
2015 6
2016 9
2017 9
2018 12
2019 12
2020 4
2021 11
2022 9
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I; PIVOTAL Investigators and Committees. Macdougall IC, et al. N Engl J Med. 2019 Jan 31;380(5):447-458. doi: 10.1056/NEJMoa1810742. Epub 2018 Oct 26. N Engl J Med. 2019. PMID: 30365356 Free article. Clinical Trial.
BACKGROUND: Intravenous iron is a standard treatment for patients undergoing hemodialysis, but comparative data regarding clinically effective regimens are limited. METHODS: In a multicenter, open-label trial with blinded end-point evaluation, we randomly assigned adults u …
BACKGROUND: Intravenous iron is a standard treatment for patients undergoing hemodialysis, but comparative data regarding clinically …
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.
Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, Isaac H, Bhandari S. Mikhail A, et al. BMC Nephrol. 2017 Nov 30;18(1):345. doi: 10.1186/s12882-017-0688-1. BMC Nephrol. 2017. PMID: 29191165 Free PMC article. Review.
As the kidney function deteriorates, together with medications and dietary restrictions, patients may develop iron deficiency, resulting in reduction of iron supply to the bone marrow (which is the body organ responsible for the production of different blood element …
As the kidney function deteriorates, together with medications and dietary restrictions, patients may develop iron deficiency, result …
Iron as a therapeutic target for Parkinson's disease.
Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D; FAIRPARK-II study group. Moreau C, et al. Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30. Mov Disord. 2018. PMID: 29380903 Review. No abstract available.
The safety of available treatment options for iron-deficiency anemia.
Muñoz M, Gómez-Ramírez S, Bhandari S. Muñoz M, et al. Expert Opin Drug Saf. 2018 Feb;17(2):149-159. doi: 10.1080/14740338.2018.1400009. Epub 2017 Nov 20. Expert Opin Drug Saf. 2018. PMID: 29103332 Review.
Confirmatory studies on the efficacy of newer oral iron formulations in this setting are needed. Compared with oral iron, short-term IV iron administration is more efficacious in ID correction, without significant safety concerns. However, long-term safety of …
Confirmatory studies on the efficacy of newer oral iron formulations in this setting are needed. Compared with oral iron, shor …
Safety of intravenous iron use in chronic kidney disease.
Kalra PA, Bhandari S. Kalra PA, et al. Curr Opin Nephrol Hypertens. 2016 Nov;25(6):529-535. doi: 10.1097/MNH.0000000000000263. Curr Opin Nephrol Hypertens. 2016. PMID: 27557350 Free PMC article. Review.
Treatment with oral iron is often inadequate and international guidelines recommend intravenous (i.v.) iron as the preferred option for the treatment of IDA in certain clinical situations. In this review, we assess the safety of using i.v. iron with a particu …
Treatment with oral iron is often inadequate and international guidelines recommend intravenous (i.v.) iron as the preferred o …
Current misconceptions in diagnosis and management of iron deficiency.
Muñoz M, Gómez-Ramírez S, Besser M, Pavía J, Gomollón F, Liumbruno GM, Bhandari S, Cladellas M, Shander A, Auerbach M. Muñoz M, et al. Blood Transfus. 2017 Sep;15(5):422-437. doi: 10.2450/2017.0113-17. Blood Transfus. 2017. PMID: 28880842 Free PMC article. Review.
The prevention and treatment of iron deficiency is a major public health goal. Challenges in the treatment of iron deficiency include finding and addressing the underlying cause and the selection of an iron replacement product which meets the needs of the pat …
The prevention and treatment of iron deficiency is a major public health goal. Challenges in the treatment of iron deficiency …
Anemia in Peritoneal Dialysis Patients; Iron Repletion, Current and Future Therapies.
Zeidan A, Bhandari S. Zeidan A, et al. Perit Dial Int. 2017 1-2;37(1):6-13. doi: 10.3747/pdi.2016.00193. Perit Dial Int. 2017. PMID: 28153964 Review.
Iron deficiency, both functional and absolute, is common in patients with chronic kidney disease (CKD), especially those requiring dialysis. Guidelines advocate treatment of iron-deficiency anemia in patients with CKD and those on peritoneal dialysis (PD). ...
Iron deficiency, both functional and absolute, is common in patients with chronic kidney disease (CKD), especially those requiring di …
Iron-rich Candida utilis improves intestinal health in weanling piglets.
Zeng Y, Zhou B, Huang L, Liu Y. Zeng Y, et al. J Appl Microbiol. 2023 Jul 4;134(7):lxad135. doi: 10.1093/jambio/lxad135. J Appl Microbiol. 2023. PMID: 37401152
AIM: This study aimed to investigate the effects of substituting inorganic iron in the diet of weanling piglets with iron-rich Candida utilis on gut morphology, immunity, barrier, and microbiota. ...The control group was fed a basal diet containing ferrous sulfate ( …
AIM: This study aimed to investigate the effects of substituting inorganic iron in the diet of weanling piglets with iron-rich …
Efficacy and safety of iron isomaltoside (Monofer()) in the management of patients with iron deficiency anemia.
Kalra PA, Bhandari S. Kalra PA, et al. Int J Nephrol Renovasc Dis. 2016 Mar 10;9:53-64. doi: 10.2147/IJNRD.S89704. eCollection 2016. Int J Nephrol Renovasc Dis. 2016. PMID: 27022297 Free PMC article. Review.
Iron isomaltoside has been shown to be effective in treating iron deficiency anemia across multiple therapeutic patient groups and compared to placebo, IV iron sucrose, and oral iron. Iron isomaltoside consists of iron and a carbohydrate …
Iron isomaltoside has been shown to be effective in treating iron deficiency anemia across multiple therapeutic patient groups …
Bioavailable Trace Metals in Neurological Diseases.
Poujois A, Devedjian JC, Moreau C, Devos D, Chaine P, Woimant F, Duce JA. Poujois A, et al. Curr Treat Options Neurol. 2016 Oct;18(10):46. doi: 10.1007/s11940-016-0426-1. Curr Treat Options Neurol. 2016. PMID: 27682263 Free article. Review.
Neurodegenerative diseases that lead to a mislocalisation of iron can be caused by a culmination of localised overload (pro-oxidant siderosis) and localised deficiency (metabolic distress). A new therapeutic concept with conservative iron chelation rescues iron …
Neurodegenerative diseases that lead to a mislocalisation of iron can be caused by a culmination of localised overload (pro-oxidant s …
137 results